Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
-
-
-
-
-
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK
-
-
-
-
-
-
-
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK
-
-
-
-
-
-
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK
-
-
-
-
-
-
-
Deutsche Bank Reiterates Buy Rating on GlaxoSmithKline (GSK:LN) (GSK)
-
-
-
-
-
-
-
Deutsche Bank Reiterates Hold Rating on GlaxoSmithKline (GSK)
-
-
-
-
-
-
-
GSK buys out Novartis in $13 billion consumer healthcare shake-up
-
-
-
-
-
-
-
Notable Analyst Rating Changes 12/9: (VOLC) (SM) (LULU) Upgraded; (GSK) (DWA) (DOV) Downgraded
-
55,959 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

